Another example of identification of druggable drivers in mouse models of BRCA1-deficient TNBC was recently provided by Liu et al.44, who analyzed transcriptional and CNA profiles of mammary tumors from our previously published KB1P and K14Cre;Trp53F/F (KP) models20. The gene discussed is BRCA1; the disease is breast cancer.